Spero Therapeutics SPRO Cash Flow Statement (2016-2026)

NASDAQ SPRO
$1.22 -0.01 (-0.82%)
As of: Aug 20, 2026 · 3:59 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-55.73M-129.95M-34.09M-26.07M-11.84M-92.37M-13.27M-11.91M-3.20M-59.57M-12.66M-17.86M-16.55M-142.66M-13.87M-107.67M-27.73M29.32M-7.38M-9.61M
Share-based Compensation (Quarter)
2.33M2.93M3.20M1.32M2.11M2.50M2.17M1.86M1.91M2.00M2.02M2.11M2.15M1.50M1.56M0.71M1.05M1.01M1.11M0.82M
Deferred Taxes (Quarter)
Asset Writedowns and Impairment (Quarter)
5.31M0.60M
Cash from Operations (Quarter)
-4.95M-27.35M-28.22M-23.03M-0.96M44.48M-12.85M-18.56M15.91M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M-5.36M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.07M-0.05M-0.02M0.01M
Depreciation & Amortization (CF) (Quarter)
0.15M0.19M0.19M0.29M0.26M0.13M0.11M0.11M0.11M0.04M0.00M
Change in Working Capital
Change in Account Payables (Quarter)
1.53M-2.06M3.68M-3.07M0.87M-1.97M-0.03M0.73M-0.21M0.28M1.69M-0.37M3.39M1.22M-5.54M-0.98M0.61M-0.70M-0.48M-0.06M
Change in Accured Expenses (Quarter)
0.13M5.29M-5.29M-0.55M-0.42M0.88M-0.11M-3.26M0.96M-0.01M-1.18M4.63M5.32M2.40M-9.54M-1.46M1.08M-2.23M-2.44M2.97M
Change in Taxes (Quarter)
-1.82M-0.29M0.08M-0.01M0.22M-0.22M
Other Working Capital Changes (Quarter)
10.89M-8.09M-0.03M-3.62M7.17M-4.21M-0.22M0.22M0.00M-0.14M-0.11M-0.07M0.04M-0.36M-0.25M0.62M-12.59M-0.20M-0.65M
Investing Activities
Capital Expenditures (Quarter)
Change in Acquisitions & Divestments (Quarter)
18.05M7.00M10.91M49.87M
Cash from Investing Activities (Quarter)
17.02M-23.27M-16.06M50.00M-0.13M
Financing Activities
Other financing activities (Quarter)
0.85M48.53M0.19M0.23M0.00M
Cash from Financing Activities (Quarter)
29.22M50.35M3.81M-53.68M6.13M14.18M0.22M0.00M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-38.90M-5.36M3.63M40.00M6.13M-0.06M0.22M0.00M
Dividend Payments
Dividends Paid - Common (Quarter)
Additional items
Change in Cash (Quarter)
41.30M-0.28M-40.47M-26.71M5.04M58.66M-12.85M-18.56M16.14M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M-5.36M
Free Cash Flow (Quarter)
-4.95M-27.35M-28.22M-23.03M-0.96M44.48M-12.85M-18.56M15.91M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M-5.36M
Net Cash Flow (Quarter)
41.30M-0.28M-40.47M-26.71M5.04M58.66M-12.85M-18.56M16.14M-17.49M5.94M-18.74M12.76M-23.40M-4.00M-17.69M17.42M-8.35M15.86M-5.36M